Literature DB >> 24434844

Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)--a review of their phytochemistry, pharmacology, toxicology and traditional use.

Gui-Lin Jin1, Yan-Ping Su1, Ming Liu1, Ying Xu1, Jian Yang1, Kai-Jun Liao1, Chang-Xi Yu2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: In the genus Gelsemium, Gelsemium elegans (Gardn. & Champ.) Benth. has been recognized as a toxic plant that is widely distributed in Southeast Asia and has been used as traditional Chinese medicine for the treatment of rheumatoid pain, neuropathic pain, spasticity, skin ulcers and cancers for many years. Gelsemium sempervirens (L.) J.St.-Hil. has been used since the nineteenth century in homeopathy for treating anxiety, neuralgia, migraine and spasmodic disorders, such as asthma and whooping cough in North America. This review aims to provide comprehensive information on the botany, traditional uses, phytochemistry, pharmacological research and toxicology of medicinal plants in the genus Gelsemium. The overall objective is to explore the evidence supporting its ethnopharmacological effectiveness.
MATERIALS AND METHODS: A literature survey was performed by searching the scientific databases Pubmed, Google Scholar, SciFinder, Scopus, Web of Science and the Chinese CNKI, in addition to traditional Chinese medicine and homeopathic texts for information on Gelsemium.
RESULTS: Plants of the genus Gelsemium have been used in traditional medicine for the treatment of migraines, neuralgia, sciatica, cancer and various types of sores. Studies into the phytochemical composition of this genus have shown that all of the species are rich sources of monoterpene indole alkaloids and that they have attracted the attention of many researchers due to their markedly diverse and complex architecture. To date, a total of 121 alkaloids have been isolated and identified from the genus. The crude extracts, as well as the monomeric compounds, from the genus possess anti-tumor, analgesic, anxiolytic, anti-inflammatory and immunomodulating pharmacological activities.
CONCLUSION: It is evident from the available literature that Gelsemium species possess potential for use as a beneficial therapeutic remedy. However, the analysis of previous pharmacological research suggests that a clear assignment of active molecules and mechanisms of action is remain lacking. Due to their high toxicity, the studies available on toxicity and safety are inadequate for providing information on clinical utilization.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alkaloids; Gelsemium; Iridoids; Pharmacology; Phytochemistry; Toxicology

Mesh:

Substances:

Year:  2014        PMID: 24434844     DOI: 10.1016/j.jep.2014.01.003

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  35 in total

Review 1.  Glycine receptors and glycine transporters: targets for novel analgesics?

Authors:  Hanns Ulrich Zeilhofer; Mario A Acuña; Jacinthe Gingras; Gonzalo E Yévenes
Journal:  Cell Mol Life Sci       Date:  2017-08-08       Impact factor: 9.261

2.  Total Synthesis of Gelsenicine via a Catalyzed Cycloisomerization Strategy.

Authors:  Eric T Newcomb; Phil C Knutson; Blaine A Pedersen; Eric M Ferreira
Journal:  J Am Chem Soc       Date:  2015-12-30       Impact factor: 15.419

3.  Koumine exhibits anxiolytic properties without inducing adverse neurological effects on functional observation battery, open-field and Vogel conflict tests in rodents.

Authors:  Chao-Jie Chen; Zhi-Feng Zhong; Zhi-Ming Xin; Long-Hui Hong; Yan-Ping Su; Chang-Xi Yu
Journal:  J Nat Med       Date:  2017-01-19       Impact factor: 2.343

4.  The analgesic effect and possible mechanisms by which koumine alters type II collagen-induced arthritis in rats.

Authors:  Gui-Lin Jin; Jian Yang; Wan-Qing Chen; Jie Wang; Hong-Qiang Qiu; Ying Xu; Chang-Xi Yu
Journal:  J Nat Med       Date:  2018-07-27       Impact factor: 2.343

5.  Functional modulation of glycine receptors by the alkaloid gelsemine.

Authors:  Cesar O Lara; Pablo Murath; Braulio Muñoz; Ana M Marileo; Loreto San Martín; Victoria P San Martín; Carlos F Burgos; Trinidad A Mariqueo; Luis G Aguayo; Jorge Fuentealba; Patricio Godoy; Leonardo Guzman; Gonzalo E Yévenes
Journal:  Br J Pharmacol       Date:  2016-06-06       Impact factor: 8.739

6.  Integration of Metabolomics and Transcriptomicsto Comprehensively Evaluate the Metabolic Effects of Gelsemium elegans on Pigs.

Authors:  Chong-Yin Huang; Kun Yang; Jun-Jie Cao; Zi-Yuan Wang; Yong Wu; Zhi-Liang Sun; Zhao-Ying Liu
Journal:  Animals (Basel)       Date:  2021-04-21       Impact factor: 2.752

7.  Toxicokinetics, in vivo metabolic profiling, and in vitro metabolism of gelsenicine in rats.

Authors:  Zheng Xiang; Jieying Qiu; Xiaoying He; Xinwei Yu
Journal:  Arch Toxicol       Date:  2022-01-23       Impact factor: 5.153

8.  Excretion, Metabolism, and Tissue Distribution of Gelsemium elegans (Gardn. & Champ.) Benth in Pigs.

Authors:  Xiao Ma; Zi-Yuan Wang; Meng-Ting Zuo; Kun Yang; Zhi-Liang Sun; Yong Wu; Zhao-Ying Liu
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.411

9.  On Gelsemium and Complementary and Alternative Medicine (CAM) in Anxiety and Experimental Neurology.

Authors:  Salvatore Chirumbolo
Journal:  Neurol Ther       Date:  2014-12-19

10.  Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.

Authors:  Hong-Qiang Qiu; Ying Xu; Gui-Lin Jin; Jian Yang; Ming Liu; Su-Ping Li; Chang-Xi Yu
Journal:  Mol Pain       Date:  2015-08-09       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.